Aktie A2N5RJ VIVUS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen VIVUS, Inc.

Aktien

A2N5RJ

US9285513084

VVUSQ

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
VIVUS LLC Announces It Will Provide Telehealth to Patients Through an Enhanced 'Engage' Program in Collaboration with UpScriptHealth
VIVUS LLC Announces Positive Topline Data from a Post-Marketing Study to Evaluate the Effect of QSYMIA
VIVUS, Inc. Promotes Santosh T. Varghese to President VIVUS Global Pharmaceutical Development
FDA Approves VIVUS LLC's QSYMIA® for the Treatment of Obesity in Adolescents Ages 12-17
VIVUS : Receives Court Approval of Joint Chapter 11 Plan of Reorganization
VIVUS, Inc. Emerged from Bankruptcy
Revised Second Amended Reorganization Plan & Disclosure Statement Approved for VIVUS, Inc.
First Motion for Exclusivity Period Extension Approved For VIVUS, Inc.
VIVUS : Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date
VIVUS INC : Other Events, Financial Statements and Exhibits (form 8-K)
Second Amended Joint Pre-Packaged Reorganization Plan Filed by VIVUS, Inc.
First Motion for Exclusivity Period Extension Filed by VIVUS, Inc.
Motion for Asset Sale Filed by VIVUS, Inc.
First Amended Joint Pre-Packaged Reorganization Plan Filed by VIVUS, Inc.
VIVUS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure (form 8-K)
VIVUS, Inc.(NasdaqGS:VVUS) dropped from S&P TMI Index
Motion for Joint Administration Approved for VIVUS, Inc.
Combined Hearing for Disclosure Statement and Plan Approved for VIVUS, Inc.
Health Care Flat As Growth Investors Seek Out Tech -- Health Care Roundup
VIVUS INC : Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2N5RJ Aktie
  4. Nachrichten VIVUS, Inc.
  5. Andere Sprachen